Medical In-Patient Rehabilitation in Rheumatoid Arthritis

This study has been completed.
Sponsor:
Collaborators:
AOK Schleswig-Holstein
BEK Nord
Draeger and Hanse BKK
DAK Schleswig-Holstein
IKK Schleswig-Holstein
TK Schleswig-Holstein
LVA Schleswig-Holstein
BfA
Deutsche Rheumaliga Schleswig-Holstein
Berufsverband Deutscher Rheumatologen
Information provided by:
University of Luebeck
ClinicalTrials.gov Identifier:
NCT00229541
First received: September 27, 2005
Last updated: October 26, 2007
Last verified: October 2007

September 27, 2005
October 26, 2007
October 2003
Not Provided
work incapacity (incidence, duration) [ Time Frame: baseline, 12 months follow-up ]
Baseline and 12-months follow-up: work incapacity (incidence, duration)
Complete list of historical versions of study NCT00229541 on ClinicalTrials.gov Archive Site
  • general health status (SF-36) [ Time Frame: baseline, 12 months follow-up ]
  • Functional capacity (FFbH-P) [ Time Frame: baseline, 12 months follow-up ]
  • Quality of life (RAQoL) [ Time Frame: baseline ]
  • Subjective prognosis of gainful employment (SPE-scale) [ Time Frame: baseline, 12 months follow-up ]
  • Somatization (SCL-90-R) [ Time Frame: baseline, 12 months follow-up ]
  • Depression [ Time Frame: baseline, 12 months follow-up ]
  • Baseline and 12-months follow-up: general health status (SF-36)
  • Functional capability (FFbH-P)
  • Quality of life (RAQoL)
  • Subjective prognosis of capability of employment (SPE)
  • Somatization (SCL-90-R)
  • Depression
Not Provided
Not Provided
 
Medical In-Patient Rehabilitation in Rheumatoid Arthritis
Medical In-Patient Rehabilitation in Rheumatoid Arthritis: Acceptance and Outcomes in Insurants of Compulsory Health Insurances and Statutory Pension Insurances (VERA)

The randomised controlled trial explores the efficacy of a counselling interview on an multidisciplinary multimodal intervention to ameliorate the somatic, mental and social medical progress of rheumatoid arthritis in gainfully employed insurants of compulsory health insurances and statutory pension insurances . Additionally, the feasibility to recruit a study population via databases of compulsory health insurances is examined.

Rheumatoid arthritis is the most prevalent inflammatory rheumatic disease. Limited participation of the individual patient accumulates with large amounts of indirect costs for society: About 40 % of the affected patients have to quit their jobs within the first three to four years after disease onset. Nevertheless, the German health care system still seems to lack an adequate supply, particularly in case of medical rehabilitation in early stages of disease. International clinical trials, reviews amd evidence-based guidelines emphasize the importance of an early multimodal multidisciplinary team care as in Germany provided by specialised clinics through three-week in-patient medical rehabilitation programs. The available study explores the efficacy of a counselling interview on an medical in-patient rehabilitation in a randomised controlled design. Exclusively, gainfully employed insurants of compulsory health insurances and statutory pension insurances are included in the study.

Secondary, to avoid the problem of a selection bias caused by recruitment via clinics or doctors, the RCT tests the possibility to recruit potential participants by data of the co-operating health insurances on RA-specific diagnoses of work incapacity, hospital discharge diagnoses, and medical prescriptions within the past 24 months.

Detailed process:

  1. Recruitment of a potential study population via health insurance data (defined search criteria: ICD-10 diagnoses M05/06/13/79 in case of work disability/hospital discharge, RA-specific medical prescriptions within the past 24 months)
  2. screening questionnaire to verify in-/exclusion criteria
  3. selection of eligible insurants (RA-criteria of American College of Rheumatology, clinical expert)
  4. baseline measurement (e.g. SF-36, RAQoL, FFbH-P, SPE)
  5. external stratified block by block randomization: intervention group (3- week medical in-patient rehabilitation) vs. control group (usual care)
  6. follow-up measurement (12 months after baseline)
  7. data transfer of health insurances and pension insurances

Comparison:

Looking at a 12-months follow-up, the intervention group (3-week medical in-patient rehabilitation) is expected to show significant enhancement in somatic, mental and social medical parameters concerning rheumatoid arthritis compared to a control group receiving usual care.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Rheumatoid Arthritis
Procedure: Counselling and 3-week medical in-patient rehabilitation
Counselling and 3-week medical in-patient rehabilitation in IG
  • Experimental: IG
    intervention group, receives counselling on medical inpatient rehabilitation by statutory health insurance, is intended to apply for a 3-wek medical inpatient rehabilitation at the co-operating clinic (Bad Bramstedt)
    Intervention: Procedure: Counselling and 3-week medical in-patient rehabilitation
  • No Intervention: KG
    control group, receives usual care
Schlademann S, Huppe A, Raspe H. [Results of a randomised controlled trial on the acceptance and the outcomes of a counselling on medical inpatient rehabilitation in gainfully employed members of statutory health insurances with rheumatoid arthritis (clinicaltrials.gov identifier NCT00229541)] Gesundheitswesen. 2007 Jun;69(6):325-35. German.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
129
March 2006
Not Provided

Inclusion Criteria:

  • Rheumatoid arthritis / psoriatic arthritis (expert decision, ACR criteria)
  • Insurant of co-operating health insurance and pension insurance
  • Gainfully employed
  • Eligible to receive a medical in-patient rehabilitation

Exclusion Criteria:

  • Polyarthritis, inflammatory intestinal diseases and diseases of connective tissue
  • Currently work disabled
  • Not able / not willing to co-operate
  • Medical in-patient rehabilitation within past 48 months
Both
20 Years to 62 Years
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00229541
FKZ 01GL0306
Yes
Not Provided
University of Luebeck
  • AOK Schleswig-Holstein
  • BEK Nord
  • Draeger and Hanse BKK
  • DAK Schleswig-Holstein
  • IKK Schleswig-Holstein
  • TK Schleswig-Holstein
  • LVA Schleswig-Holstein
  • BfA
  • Deutsche Rheumaliga Schleswig-Holstein
  • Berufsverband Deutscher Rheumatologen
Principal Investigator: Heiner Raspe, Prof.Dr.Dr. Institute for Social Medicine, University of Luebeck
University of Luebeck
October 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP